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AbstrAct
Leukoplakia is a potentially malignant disorder of the oral mucosa. It usually presents as a white patch in the oral cavity. The term leukoplakia 
represents a clinical entity and should preferably be used only for provisional diagnosis and not after histopathology. There are various 
terminologies and definitions associated with leukoplakia since past times. In this article, we have reviewed the literature to provide a 
comprehensive update on leukoplakia. 
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IntroductIon
Leukoplakia is a frequently occurring potentially malignant lesion of 
the oral cavity. Hungarian dermatologist, Schwimmer in 1877, coined 
the term leukoplakia. It is derived from a Greek word Leucos which 
means white and Plakia, meaning a patch.[1] Leukoplakia has been 
mentioned in the literature since 1969, but it was first defined by 
WHO in 1978,[2] followed by other authors and even revised by WHO.
World Health Organisation (1978): Defined leukoplakia as a 
white patch or plaque that cannot be characterized clinically or 
pathologically as any other disease.[3]
1st International Conference on oral leukoplakia. Malmo, Sweden 
(1984): A white patch or plaque that cannot be characterized clinically 
or pathologically as any other disease and is not associated with any 
physical or chemical causative agent except the use of tobacco.[4]
International symposium. Uppsala, Sweden (1994): Oral 
leukoplakia is a predominantly white lesion of the oral mucosa that 
cannot be characterized as any other definable lesion; some oral 
leukoplakias will transform into cancer.[5]
Warnakulasuriya et al. (2007): Leukoplakia should be used to 
recognize white plaques of questionable risk having excluded 
(other) known diseases or disorders that carry no increased risk 
for cancer.[4]
Van der Waal 2012: “A predominantly white lesion or plaque 
of questionable behaviour having excluded, clinically and 
histopathologically, any other definable white disease or disorder”.[6]
It should be noted that leukoplakia is a clinical term only and 
the final diagnosis will be as per the histopathological evaluation.[7]
EtIology
Etiology for oral leukoplakia is multifactorial, but the tobacco in 
both forms seems to be associated in most of the lesions.  The 
another frequently linked factor is alcohol but the use of alcohol 
as an independent aetiological factor in the development of oral 
leukoplakia, is still questionable.[8]
Other factors related to leukoplakia include Sanguinaria, 
Tertiary Syphilis, Deficiency of vitamins including vitamin A, B 
complex, C, E beta-carotene, Trauma, Viral Infection.1 Candidiasis 
is also considered an etiologic factor of leukoplakia but its possible 
role in the etiopathogenesis and in malignant transformation is 
still unclear.[9]  
Incidence
In a study on large random samples, carried out in several 
geographic areas with various kinds of tobacco usage, the annual 
age-adjusted incidence rates of leukoplakia per 1000 population 
per year varied from 1.1–2.4 among men and from 0.2–1.3 among 
women; the prevalence varied from 0.2 to 4.9%.[10]
In another study conducted by Pindborg et al. in 1967 on a large 
prospective study (N = 10,000) in India and found that 3.28% of 
patients (n = 328) had leukoplakia.6 In a study done on the Swedish 
population, a prevalence rate of 3.6% was recorded.[11]
Age and Gender
The onset is usually seen after the age of 30 years of age, with peak 
incidence seen above the age of 50 years. The male to female ratio 
mainly depends on the geographic distribution of the disease but 
a strong male predominance in different parts in India, to almost 
1:1 in the Western world.[8]
ClinicalTypes
According to WHO 19805[12]
Homogeneous leukoplakia has been defined as a predominantly 
white lesion of uniform flat, thin appearance that may exhibit 
shallow cracks and has a smooth, wrinkled or corrugated surface 
with a constant texture throughout.
Non-homogeneous leukoplakia has been defined as a 
predominantly white or white-and-red lesion (erythroleukoplakia) 
that may be irregularly flat, nodular or exophytic. The nodular 
lesions are characterized by white patches or nodules on an 
erythematous base.
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According to WHO (1998)[13]
• Thin, smooth leukoplakia-Translucent thin grey soft flat plaques 
usually with sharply demarcated borders. 
• Thick, fissured leukoplakia - 2/3 of white plaques has a distinctly 
white appearance, fissured and is leathery to palpation. 
• Granular, verruciform leukoplakia - Lesions have surface 
irregularities of nodular or granular nature with verrucous 
appearance. 
• Erythroleukoplakia - Lesion showing intermixed red and white 
areas.
Warnakulasuriya et al. (2007)[14] 
Homogeneous leukoplakia - Homogeneous lesions are uniformly 
flat, thin, and exhibit shallow cracks of the surface keratin. The risk 
of malignant transformation is relatively low.
Non - Homogenous leukoplakia 
• Speckled leukoplakia - Mixed, white and red, but retaining the 
predominantly white character
• Nodular leukoplakia - Small polypoid outgrowths, rounded red 
or white excrescences
• Verrucous-leukoplakia - Wrinkled or corrugated surface 
appearance.
Proliferative verrucous leukoplakia first described by Hansen (1985) 
is a subtype of verrucous leukoplakia which is characterized by 
an aggressive evolution, resistance to treatment, a multifocal 
appearance, higher degree of recurrence.[15] It also has a high risk 
of transformation in oral carcinoma.[2]
Candidal Leukoplakia: It is an extremely chronic form of oral 
candidiasis seen as a firm, white, leathery plaques often found on 
the buccal mucosa, lips, and tongue. PAS staining is often used to 
differentiate it from other forms. Epithelial dysplasia is known to 
occur 4 to 5 times more frequently in candida leukoplakia than in 
leukoplakia. Carcinomatous change, also occur more frequently 
in this type.[1]
HIstology
The histology of oral leukoplakia may vary from atrophy of the 
epithelium to hyperplasia with or without hyperkeratosis or may 
end into epithelial dysplasia or even carcinoma. Dysplasia reflects 
histological changes that are followed by the loss of uniformity or 
the architecture of the epithelial cells. The features suggesting 
dysplastic changes according to WHO criteria for epithelial 
dysplasia can be summed as follows:
Architectural Changes[16]
Irregular epithelial stratification, drop shaped rete ridges, loss of 
polarity of basal cells, abnormal superficial mitosis, premature 
keratinization in single cells (dyskeratosis), increased number of 
mitotic figures, Keratin pearls within rete ridges, loss of epithelial 
cell cohesion.
Cellular Changes[16]
Abnormal variation in Nuclear size (anisonucleosis), abnormal 
variation in nuclear shape (nuclear pleomorphism), abnormal 
variation in cell shape (cellular pleomorphism), increased nuclear-
cytoplasmic ratio, abnormal variation in cell shape (anisocytosis) 
atypical mitotic figures, hyperchromasia, increased number and 
size of nucleoli.
Epithelial dysplasia, if present, may range from mild to severe. 
In some instances, carcinoma in situ and even squamous cell 
carcinoma are encountered histologically.  It has been observed 
that the degree of epithelial dysplasia usually correlates with the 
age of the patient.[17]
Diagnosis
Clinical visual examination of the oral mucosa is the first and most 
frequent method for oral screening the patch on the oral mucosa 
followed by scrapping it with a sterile gauze piece. The experience 
and skill of the clinician are very important in such screening 
procedures, but it is not a method by which the risk level of the 
lesion can be calculated.[2] So a combination of clinical history 
and histopathology of the lesion are important in making a final 
diagnosis. 
There are various other adjunctive screening aids which have 
been used to assess the lesion these include vital staining with 
toluidine blue, brush biopsy examination, autofluorescence, 
chemiluminescence, and biomarker assessment (from saliva, serum, 
or exfoliated cells).[18]
In addition to this there are numerous molecular markers 
such as aberrant expression of p16INK4a and Ki-67, and loss of 
heterozygosity at 9p and mutated TP53[19,20] but at present, there 
is no single marker or a set of markers which can be reliably used 
to predict malignant transformation of oral leukoplakia in an 
individual patient.[14]
Management
Management of leukoplakia is directed towards detecting any 
malignant transformation arising in the lesion. Management of 
leukoplakia starts with the cessation of tobacco use, followed by 
observation of the lesion. There are no strict guidelines that can 
be applied regarding the duration of follow-up examinations. 
In general, a long term follow-up examination is advised at 6-12 
month intervals in patients who have not or not successfully been 
treated for their leukoplakia. Patients who, after treatment, remain 
disease-free for 3 years need perhaps no longer be followed-up.[21]
Various antifungal agents are given when Candida-associated 
leukoplakia is suspected. Other Management techniques include 
Chemoprevention- Retinoids, Vitamins (A, C, E), carotenoids, topical 
therapy- Bleomycin, Vitamin A, photodynamic therapy, surgical 
excision with or without grafting, electrocoagulation, cryosurgery 
and Laser surgery1 A Recent studies have reviewed the use of 
carbon dioxide laser for management of leukoplakia and have 
shown that the laser technique was reliable and reproducible with 
low morbidity.[6]
According to various studies, the recurrence of oral leukoplakia 
after surgical treatment has been reported in 10%[22] to 15%[6] cases. 
In Such recurrent lesions, the excision should be done, including 
2 mm to 3 mm of the surrounding healthy margin.[23] Patients 
having leukoplakia as a provisional diagnosis and a histopathologic 
diagnosis of SCC should be referred to an oncology department for 
further evaluation.[6]
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